DM Flashcards
(42 cards)
Cells within islets of langerhans
alpha cells secrete glucagon, beta cells secrete insulin, delta cells secrete somatostatin, gamme cells secrete pancreatic polypeptide
What is negative inhibitor for growth hormone?
somatostatin
Insulin lowers blood glucose in 3 different ways:
inhibits glucagon secretion from alpha cells, increases glucose uptake by adipose tissue and skeletal muscle, and 3. decreases hepatic glucose production (liver produces less)
populations most affected by DM
non-hispanic black men
Age of onset in Type I DM
bimodal- 4 to 6, and 10-14. Majority diagnosed in childhood.
risk factor ethnicity in DM Type I vs. II
Type I- non hispanic whites at risk. Type II- non hispanic blacks at risk
Type IA vs. Type IB DM (idiopathic type I DM)
1a- autoimmune destruction of beta cells (MOST CASES)
ib- non-autoimmune beta cell destruction
3 presentations in Type I DM
- classic new onset: polyuria, polydipsia, weight loss. Ill, lethargy, visual disturbances. 2. Diabetic Ketoacidosis- polyuria, polydipsia, weight loss. Fruity smelling breath, drowsiness, lethargy. 3. Silent
Most important modifiable risk factor for Type II DM
Obesity, sedentary lifestyle, highfat diet
Ketonuria more indicative of type I or type II DM
type I
what test to order if concerned about gestational diabetes in pregnant woman?
oral glucose tolerance test
Hemoglobin A1c helpful in diagnosis of …
type 2 diabetes
Patient with hemoglobin A1C of 6.5%. Next step?
Check for hyperglycemia by doing fasting blood glucose to confirm DM
Impaired glucose TOLERANCE
140-199 mg/dl blood glucose at 120 minutes
If want to check glucose levels in sickle cell anemic patient, which test would you order?
serum fructosamine- gives you good idea of recent blood glucose control over the last 1-2 weeks.
C peptide and insulin levels in T1
Both decreased
C peptide and insulin levels in T2
Both increased
Type I DM controlled insulin and c peptide levels
C peptide decreased, insulin increased (because taking exogenous insulin)
how does metformin work?
decreases hepatic gluconeogenesis and lipogenesis
Metformin is contraindicated in…
patients with severe kidney or liver disease, and alcoholics
Metformin associated with weight gain?
NO!
Can hypoglycemia occur in patient taking metformin?
NO!
MOA sulfonylureas
stimulate insulin release from pancreatic beta cells
sulfonylureas contraindicated in
patients with chronic liver or kidney disease (like metformin)